Search

Read more on the Boehringer Ingelheim launched Animal Health vaccine, aimed at protecting poultry from three different diseases.

Boehringer Ingelheim and Yale Clinical and Translational Research Accelerator collaborate to explore potential benefits of digital health technologies for adults with heart failure

Yew Looi Liew Named President of U.S. Human Pharma for Boehringer Ingelheim Pharmaceuticals, Inc.

Queen Latifah and Bernie Williams star in Boehringer Ingelheim’s “Beyond Breathless” documentary on A&E

Queen Latifah and Bernie Williams star

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

Boehringer Ingelheim Animal Health USA Establishes Pawru, Inc.

Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer

Partnering in Retinal Health

Our partnering interests in retinal diseases offer opportunities for collaboration to complement our pipeline and advance treatment and delivery.

Big Little Things: In cancer, small things make a big impact

Little things can be a big deal when you are living with or treating cancer. “Big Little Things” celebrates the small things that have a big impact.

Partnering with Boehringer Ingelheim

Information on partnering with Boehringer Ingelheim including how the company enables new science, partnering interests and key facts on the R&D pipeline.

Boehringer Ingelheim to unveil oncology research at WCLC

Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC, demonstrating strength of portfolio

Protecting a Way of Life in Haiti | Boehringer Ingelheim US

Click here to find out how Boehringer Ingelheim is helping to protect a way of life in Haiti by producing a custom swine vaccine to support the island.

Arising Vaccines to Help Zoo Elephants | Boehringer Ingelheim US

Find out how Boehringer Ingelheim is developing vaccines to help North African zoo elephants suffering from deadly infections and illness.

Bigger Role in Ensuring Food Security | Boehringer Ingelheim US

As the population of the earth grows, animal health becomes fundamental in ensuring well-being and the global protein supply. Click here to find out more.

Innovation in Immunology | Human Health | Boehringer Ingelheim US

BI's Immunology & Respiratory research combines our ability to address unmet medical needs with pioneering patient-centered approaches.

Experience our culture during your interview process

Discover if our company is the right fit for you.

Boehringer inhalers now available at $35 a month for eligible patients

Boehringer COPD and asthma inhalers now available at $35 a month for eligible patients

USDA & BI Expand Research Opportunities | Boehringer Ingelheim US

Find out more about how veterinary students will work with USDA scientists in researching emerging diseases related to both animal and public health.

Making Toys for Shelter Animals | Boehringer Ingelheim US

Find out how nearly 400 Boehringer Ingelheim employees came together to make toys out of donated t-shirts for animals living in shelters across the USA.

Canine Lyme Disease: What You Need to Know | Boehringer Ingelheim US

Click here to discover all you need to know about lyme disease in dogs; causes, symptoms, prevention, detection and treatment.

COVID-19: Boehringer Ingelheim steps up effort with Global Support Program

Search

New study results show Tradjenta® (linagliptin) reduces blood sugar in adults with type 2 diabetes at risk for kidney impairment

U.S. FDA Approves Once-daily Jentadueto® XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes

FDA Mini-Sentinel Assessment Reinforces Safety Data of Pradaxa® (dabigatran etexilate mesylate)

Lars Dreesmann Named President of Boehringer Ingelheim Fremont, Inc.

BI Launches Vaccine to Protect Poultry | Boehringer Ingelheim US

Boehringer Ingelheim and Yale Clinical and Translational Research Accelerator collaborate to explore potential benefits of digital health technologies for adults with heart failure

Yew Looi Liew Named President of U.S. Human Pharma for Boehringer Ingelheim Pharmaceuticals, Inc.

Queen Latifah and Bernie Williams star in Boehringer Ingelheim’s “Beyond Breathless” documentary on A&E

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

Boehringer Ingelheim Animal Health USA Establishes Pawru, Inc.

Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer

Partnering in Retinal Health

Big Little Things: In cancer, small things make a big impact

Partnering with Boehringer Ingelheim

Boehringer Ingelheim to unveil oncology research at WCLC

Protecting a Way of Life in Haiti | Boehringer Ingelheim US

Arising Vaccines to Help Zoo Elephants | Boehringer Ingelheim US

Bigger Role in Ensuring Food Security | Boehringer Ingelheim US

Innovation in Immunology | Human Health | Boehringer Ingelheim US

Experience our culture during your interview process

Boehringer inhalers now available at $35 a month for eligible patients

USDA & BI Expand Research Opportunities | Boehringer Ingelheim US

Making Toys for Shelter Animals | Boehringer Ingelheim US

Canine Lyme Disease: What You Need to Know | Boehringer Ingelheim US

COVID-19: Boehringer Ingelheim steps up effort with Global Support Program

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers

Search

New study results show Tradjenta® (linagliptin) reduces blood sugar in adults with type 2 diabetes at risk for kidney impairment

U.S. FDA Approves Once-daily Jentadueto® XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes

FDA Mini-Sentinel Assessment Reinforces Safety Data of Pradaxa® (dabigatran etexilate mesylate)

Lars Dreesmann Named President of Boehringer Ingelheim Fremont, Inc.

BI Launches Vaccine to Protect Poultry | Boehringer Ingelheim US

Boehringer Ingelheim and Yale Clinical and Translational Research Accelerator collaborate to explore potential benefits of digital health technologies for adults with heart failure

Yew Looi Liew Named President of U.S. Human Pharma for Boehringer Ingelheim Pharmaceuticals, Inc.

Queen Latifah and Bernie Williams star in Boehringer Ingelheim’s “Beyond Breathless” documentary on A&E

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

Boehringer Ingelheim Animal Health USA Establishes Pawru, Inc.

Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer

Partnering in Retinal Health

Big Little Things: In cancer, small things make a big impact

Partnering with Boehringer Ingelheim

Boehringer Ingelheim to unveil oncology research at WCLC

Protecting a Way of Life in Haiti | Boehringer Ingelheim US

Arising Vaccines to Help Zoo Elephants | Boehringer Ingelheim US

Bigger Role in Ensuring Food Security | Boehringer Ingelheim US

Innovation in Immunology | Human Health | Boehringer Ingelheim US

Experience our culture during your interview process

Boehringer inhalers now available at $35 a month for eligible patients

USDA & BI Expand Research Opportunities | Boehringer Ingelheim US

Making Toys for Shelter Animals | Boehringer Ingelheim US

Canine Lyme Disease: What You Need to Know | Boehringer Ingelheim US

COVID-19: Boehringer Ingelheim steps up effort with Global Support Program